Management of supraglottic squeeze in adductor spasmodic dysphonia: A new technique

Laryngoscope

Volumn 117, Issue 11, 2007, Pages 2082-2084

  Young, Nwanmegha ^a,b   Blitzer, Andrew ^a  

^a Columbia University ^*  (United States)

^b New York Center for Voice and Swallowing Disorders   (United States)

Author keywords

Botulinum toxin; Hyperadduction; Spasmodic dysphonia; Thyrohyoid

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

ADULT; ARTICLE; CASE REPORT; DYSPHONIA; ELECTROMYOGRAM; FEMALE; GLOTTIS; HUMAN; INJECTION; LARYNGOSCOPY; LARYNX MUSCLE; PRIORITY JOURNAL; TREATMENT OUTCOME; VOCAL CORD DISORDER; VOICE;

BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; ELECTROMYOGRAPHY; FEMALE; FIBER OPTICS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VOICE DISORDERS; VOICE QUALITY;

EID: 35848965018     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e318124a97b     Document Type: Article

References (6)

1. Blitzer A, Brin MF, Stewart CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 1998;108:1435-1441.
2. Murry T, Woodson GE. Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy. J Voice 1995;9:460-465.
3. Koufman JA, Blalock PD. Classification and approach to patients with functional voice disorders. Ann Otol Rhinol Laryngol 1982;91:372-377.
4. Leonard R, Kendall K Differentiation of spasmodic and psychogenic dysphonias with phonoscopic evaluation. Laryngoscope 1999;109:295-300.
5. Blitzer A, Brin MF, Fahn S, et al. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia). Laryngoscope 1988;98:193-197.
6. Amin MR. Thyrohyoid approach for vocal fold augmentation Ann Otol Rhinol Laryngol 2006;115:699-702.